Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: The first Asian report

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1501-1511

  Park, Tai Sun ^a   Hong, Yoonki ^b   Lee, Jae Seung ^a   Oh, Sang Young ^a   Lee, Sang Min ^a   Kim, Namkug ^a   Seo, Joon Beom ^a   Oh, Yeon Mok ^a   Lee, Sang Do ^a   Lee, Sei Won ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Bronchoscopy; Chronic obstructive pulmonary disease; Collateral ventilation; Fissure integrity; Treatment outcome

Indexed keywords

AGED; ARTICLE; BRONCHOSCOPIC LUNG VOLUME REDUCTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DEVICE SAFETY; DISEASE SEVERITY; EMPHYSEMA; EMPYEMA; ENDOBRONCHIAL VALVE; FEMALE; FORCED EXPIRATORY VOLUME; HEART VENTRICLE FIBRILLATION; HEMOPTYSIS; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PHYSICAL CAPACITY; PNEUMONIA; PNEUMOTHORAX; PROSPECTIVE STUDY; RESPIRATORY THERAPEUTIC DEVICE; TENSION PNEUMOTHORAX; TUBERCULOSIS; VALVE MIGRATION; ADVERSE EFFECTS; BRONCHOSCOPY; EXERCISE TEST; LUNG; LUNG RESECTION; LUNG VOLUME; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY EMPHYSEMA; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; SPIROMETRY; TERTIARY CARE CENTER; TIME FACTOR; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

AGED; BRONCHOSCOPY; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PNEUMONECTOMY; PNEUMOTHORAX; PROSPECTIVE STUDIES; PULMONARY EMPHYSEMA; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; TERTIARY CARE CENTERS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84938343925     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S85744     Document Type: Article

References (36)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
3. Lee JH, Lee YK, Kim EK, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2009;104(4):542–549.
4. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg. 1996;112(5):1319–1329. discussion 1329–1330.
5. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109(1):106–116. discussion 116–109.
6. Fishman A, Martinez F, Naunheim K, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073.
7. Herth FJ, Gompelmann D, Ernst A, Eberhardt R. Endoscopic lung volume reduction. Respiration. 2010;79(1):5–13.
8. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743.
9. Bhome AB, Brashier B. Profiles of chronic obstructive lung disease: characteristics of stable chronic obstructive lung disease in different parts of Asia. Curr Opin Pulm Med. 2014;20(2):165–172.
10. Eisner MD, Anthonisen N, Coultas D, et al; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718.
11. Lee SW, Kim YS, Kim DS, Oh YM, Lee SD. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci. 2011;26(2): 268–273.
12. Oh YM, Bhome AB, Boonsawat W, et al. Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis. 2013;8: 31–39.
13. Wu J, Dalal K. Tuberculosis in Asia and the pacific: the role of socioeconomic status and health system development. Int J Prev Med. 2012;3(1):8–16.
14. Menezes AM, Hallal PC, Perez-Padilla R, et al; Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30(6):1180–1185.
15. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006;61(3):259–266.
16. Park TS, Hong Y, Lee JS, et al. Efficacy of bronchoscopic lung volume reduction by endobronchial valves in patients with heterogeneous emphysema: report on the first Asian cases. J Korean Med Sci. 2014; 29(10):1404–1410.
17. Flandes Aldeyturriaga J. Bronchoscopic lung volume reduction: 7 lessons learned. Arch Bronconeumol. 2012;48(7):221–222.
18. Strange C, Herth FJ, Kovitz KL, et al. Design of the endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med. 2007;7:10.
19. Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–308.
20. Herth FJ, Noppen M, Valipour A, et al; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012;39(6):1334–1342.
21. Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJ. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration. 2010;80(5):419–425.
22. Chae EJ, Kim N, Seo JB, et al. Prediction of postoperative lung function in patients undergoing lung resection: dual-energy perfusion computed tomography versus perfusion scintigraphy. Invest Radiol. 2013;48(8):622–627.
23. Chae EJ, Seo JB, Jang YM, et al. Dual-energy CT for assessment of the severity of acute pulmonary embolism: pulmonary perfusion defect score compared with CT angiographic obstruction score and right ventricular/left ventricular diameter ratio. AJR Am J Roentgenol. 2010;194(3):604–610.
24. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255.
25. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111–124.
26. Puhan MA, Chandra D, Mosenifar Z, et al; National Emphysema Treatment Trial (NETT) Research Group. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784–790.
27. Jones PW. St George’s respiratory questionnaire: MCID. COPD. 2005;2(1):75–79.
28. Sciurba FC, Ernst A, Herth FJ, et al; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244.
29. Gompelmann D, Herth FJ, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–491.
30. Venuta F, Anile M, Diso D, et al. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J. 2012;39(5):1084–1089.
31. Valipour A, Herth FJ, Burghuber OC, et al; VENT Study Group. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–396.
32. Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax. 2014;69(3):280–286.
33. Reymond E, Jankowski A, Pison C, et al. Prediction of lobar collateral ventilation in 25 patients with severe emphysema by fissure analysis with CT. AJR Am J Roentgenol. 2013;201(4):W571–W575.
34. Gompelmann D, Eberhardt R, Herth FJ. Collateral ventilation. Respiration. 2013;85(6):515–520.
35. Shah PL, Herth FJ. Dynamic expiratory airway collapse and evaluation of collateral ventilation with Chartis. Thorax. 2014;69(3):290–291.
36. Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema–potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–521.